Interactions between NO and reactive oxygen species: Pathophysiological importance in atherosclerosis, hypertension, diabetes and heart failure

Cardiovascular Research

Volumn 43, Issue 3, 1999, Pages 562-571

  Kojda, Georg ^a   Harrison, David ^b  

^a Institut für Pharmakologie   (Germany)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NITRIC OXIDE; NITRIC OXIDE SYNTHASE; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; SUPEROXIDE; XANTHINE OXIDASE;

ATHEROSCLEROSIS; BIOSYNTHESIS; BLOOD VESSEL WALL; CORONARY ARTERY DISEASE; CYTOLOGY; DIABETES MELLITUS; ENDOTHELIUM INJURY; ENZYME ACTIVITY; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; MOLECULAR BIOLOGY; MOLECULAR INTERACTION; NONHUMAN; OXIDATIVE STRESS; PATHOGENESIS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW;

EID: 0033566888     PISSN: 00086363     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0008-6363(99)00169-8     Document Type: Review

References (100)

1. Jayakody T.L., Senaratne M.P.J., Thompson A.B.R., Kappagoda C.T. Cholesterol feeding impairs endothelium-dependent relaxation of rabbit aorta. Can J Physiol Pharmacol. 63:1985;1206-1209.
2. Freiman P.C., Mitchell G.G., Heistad D.D., Armstrong M.L., Harrison D.G. Atherosclerosis impairs endothelium-dependent vascular relaxation to acetylcholine and thrombin in primates. Circ Res. 58:1986;783-789.
3. Ludmer P.L., Selwyn A.P., Shook T.L., et al. Paradoxical vasoconstriction induced by acetylcholine in atherosclerotic coronary arteries. N Engl J Med. 315:1986;1046-1051.
4. Golino P., Piscione F., Willerson J.T., et al. Divergent effects of serotonin on coronary-artery dimensions and blood flow in patients with coronary atherosclerosis and control patients. N Engl J Med. 324:1991;641-648.
5. Zeiher A.M., Drexler H., Saurbier B., Just H. Endothelium-mediated coronary blood flow modulation in humans. Effects of age, atherosclerosis, hypercholesterolemia, and hypertension. J Clin Invest. 92:1993;652-662.
6. Moncada S., Higgs A. Mechanisms of disease: The L-arginine-nitric oxide pathway. N Engl J Med. 329:1993;2002-2012.
7. Busse R., Fleming I. Endothelial dysfunction in atherosclerosis. J Vasc Res. 33:1996;181-194.
8. Harrison D.G. Cellular and molecular mechanisms of endothelial cell dysfunction. J Clin Invest. 100:(9):1997;2153-2157.
9. Alexander R.W. Hypertension and the pathogenesis of atherosclerosis: Oxidative stress and the mediation of arterial inflammatory response: A new perspective. Hypertension. 25:1995;155-161.
10. Griendling K.K., Minieri C.A., Ollerenshaw J.D., Alexander R.W. Angiotensin II stimulates NADH and NADPH oxidase activity in cultured vascular smooth muscle cells. Circ Res. 74:1994;1141-1148.
11. DeKeulenaer G.W., Alexander R.W., Ushio-Fukai M., Ishizaka N., Griendling K.K. Tumor necrosis factor-a activates a p22phox-based NADH oxidase in vascular smooth muscle cells. Biochem J. 329:1998;653-657.
12. Wang H.D., Pagano P.J., Du Y., et al. Superoxide anion from the adventitia of the rat thoracic aorta inactivates nitric oxide. Circ Res. 82:(7):1998;810-818.
13. Griendling K.K., Ushio-Fukai M. Redox control of vascular smooth muscle proliferation. J Lab Clin Med. 132:1998;9-15.
14. Jones S.A., O'Donnell V.B., Wood J.D., et al. Expression of phagocyte NADPH oxidase components in human endothelial cells. Am J Physiol. 271:1996;H1626-H1634.
15. Fukui T., Lassegue B., Kai H. cDNA cloning and mRNA expression of cytochrome b558 a-subunit in rat vascular smooth muscle cells. Biochim Biophys Acta. 1231:1995;215-219.
16. Ushio-Fukai M., Zafari A.M., Fukui T., Ishizaka N., Griendling K.K. p22phox is a critical component of the superoxide-generating NADH/NADPH oxidase system and regulates angiotensin II-induced hypertrophy in vascular smooth muscle cells. J Biol Chem. 271:1996;23317-23321.
17. Rajagopalan S., Kurz S., Munzel T., et al. Angiotensin II-mediated hypertension in the rat increases vascular superoxide production via membrane NADH/NADPH oxidase activation. Contribution to alterations of vasomotor tone. J Clin Invest. 97:1996;1916-1923.
18. Fukui T., Ishizaka N., Rajagopalan S., et al. p22phox mRNA expression and NADPH oxidase activity are increased in aortas from hypertensive hypertensive rats. Circ Res. 80:(1):1997;45-51.
19. Hishikawa K., Lüscher T.F. Pulsatile stretch stimulates superoxide production in human aortic endothelial cells. Circulation. 96:1997;3610-3616.
20. Hishikawa K., Oemar B.S., Yang Z., Lüscher T.F. Pulsatile stretch stimulates superoxide production and activates nuclear factor-kappa B in human coronary smooth muscle. Circ Res. 81:1997;797-803.
21. Howard A.B., Alexander R.W., Griendling K.K., Nerem R.M., Taylor W.R. Cyclic strain induces an oxidative stress in endothelial cells. Am J Physiol. 272:(2 Pt 1):1997;C421-C427.
22. Sanders S.A., Eisenthal R., Harrison R. NADH oxidase activity of human xanthine oxidoreductase. Generation of superoxide anion. Eur J Biochem. 245:1997;541-548.
23. Ohara Y., Peterson T.E., Harrison D.G. Hypercholesterolemia increases endothelial superoxide anion production. J Clin Invest. 91:1993;2546-2551.
24. White C.R., Darley-Usmar V., Berrington W.R., et al. Circulating plasma xanthine oxidase contributes to vascular dysfunction in hypercholesterolemic rabbits. Proc Natl Acad Sci USA. 93:1996;8745-8749.
25. Rouquette M., Page S., Bryant R., et al. Xanthine oxidoreductase is asymmetrically localised on the outer surface of human endothelial and epithelial cells in culture. FEBS Lett. 426:1998;397-401.
26. 2+/calmodulin-dependent formation of hydrogen peroxide by brain nitric oxide synthase. Biochem J. 281:1992;627-630.
27. Pou S., Pou W.S., Bredt D.S., Snyder S.H., Rosen G.M. Generation of superoxide by purified brain nitric oxide synthase. J Biol Chem. 267:1992;24173-24176.
28. Hobbs A.J., Fukuto J.M., Ignarro L.J. Formation of free nitric oxide from L-arginine by nitric oxide synthase: Direct enhancement of generation by superoxide dismutase. Proc Natl Acad Sci USA. 91:1994;10992-10996.
29. Xia Y., Dawson V.L., Dawson T.M., Snyder S.H., Zweier J.L. Nitric oxide synthase generates superoxide and nitric oxide in arginine-depleted cells leading to peroxynitrite-mediated cellular injury. Proc Natl Acad Sci USA. 93:1996;6770-6774.
30. Vasquez-Vivar J., Kalyanaraman B., Martasek P., et al. Superoxide generation by endothelial nitric oxide synthase: the influence of cofactors. Proc Natl Acad Sci USA. 95:(16):1998;9220-9225.
31. Pritchard K.A. Jr., Groszek L., Smalley D.M., et al. Native low-density lipoprotein increases endothelial cell nitric oxide synthase generation of superoxide anion. Circ Res. 77:1995;510-518.
32. -: A pulse radiolysis study. Free Radic Biol Med. 19:1995;505-510.
33. Beckman J.S., Crow J.P. Pathological implications of nitric oxide, superoxide and peroxynitrite formation. Biochem Soc Trans. 21:1993;330-334.
34. Beckman J.S., Beckman T.W., Chen J., Marshall P.A., Freeman B.A. Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and superoxide. Proc Natl Acad Sci USA. 87:1990;1620-1624.
35. Yang G., Candy T.E.G., Boaro M., et al. Free radical yields from the homolysis of peroxynitrous acid. Free Radic Biol Med. 12:1992;327-330.
36. Villa L.M., Salas E., Darley-Usmar V.M., Radomski M.W., Moncada S. Peroxynitrite induces both vasodilatation and impaired vascular relaxation in the isolated perfused rat heart. Proc Natl Acad Sci USA. 91:1994;12383-12387.
37. Liu S., Beckman J.S., Ku D.D. Peroxynitrite, a product of superoxide and nitric oxide, produces coronary vasorelaxation in dogs. J Pharmacol Exp Ther. 268:1994;1114-1121.
38. Tarpey M.M., Beckman J.S., Ischiropoulos H., Gore J.Z., Brock T.A. Peroxynitrite stimulates vascular smooth muscle cell cyclic GMP synthesis. FEBS Lett. 364:1995;314-318.
39. Radi R., Beckman J.S., Bush K.M., Freeman B.A. Peroxynitrite-induced membrane lipid peroxidation: The cytotoxic potential of superoxide and nitric oxide. Arch Biochem Biophys. 288:1991;481-487.
40. White C.R., Brock T.A., Chang L.-Y., et al. Superoxide and peroxynitrite in atherosclerosis. Proc Natl Acad Sci USA. 91:1994;1044-1048.
41. Yamamoto H., Bossaller C., Cartwright J., Henry P.D. Videomicroscopic demonstration of defective cholinergic arteriolar vasodilation in atherosclerotic rabbit. J Clin Invest. 81:1988;1752-1758.
42. Sellke F.W., Armstrong M.L., Harrison D.G. Endothelium-dependent vascular relaxation is abnormal in the coronary microcirculation of atherosclerotic primates. Circulation. 81:1990;1586-1593.
43. Kuo L., Davis M.J., Cannon M.S., Chilian W.M. Pathophysiological consequences of atherosclerosis extend into the coronary microcirculation: Restoration of endothelium-dependent responses by L-arginine. Circ Res. 70:1992;465-476.
44. Zeiher A.M., Drexler H., Wollschläger H., Just H. Endothelial dysfunction of coronary microvasculature is associated with impaired coronary blood flow regulation in patients with early atherosclerosis. Circulation. 84:1991;1984-1992.
45. Creager M.A., Cooke J.P., Mendelsohn M.E., et al. Impaired vasodilation of forearm resistance vessels in hypercholesterolemic humans. J Clin Invest. 86:1990;228-234.
46. Minor R.L., Myers P.R., Guerra R.J., Bates J.N., Harrison D.G. Diet-induced atherosclerosis increases the release of nitrogen oxides from rabbit aorta. J Clin Invest. 86:1990;2109-2116.
47. Mügge A., Elwell J.H., Peterson T.E., et al. Chronic treatment with polyethylene-glycolated superoxide dismutase partially restores endothelium-dependent vascular relaxations in cholesterol-fed rabbits. Circ Res. 69:1991;1293-1300.
48. Miller F.J. Jr., Gutterman D.D., Rios C.D., Heistad D.D., Davidson B.L. Superoxide production in vascular smooth muscle contributes to oxidative stress and impaired relaxation in atherosclerosis. Circ Res. 82:1998;1298-1305.
49. Oishi K., Raynor R.L., Charp P.A., Kuo J.F. Regulation of protein kinase C by lysophospholipids. Potential role in signal transduction. J Biol Chem. 263:1988;6865-6871.
50. Ohara Y., Peterson T.E., Zheng B., Kuo J.F., Harrison D.G. Lysophosphatidylcholine increases vascular superoxide anion production via protein kinase C activation. Arterioscler Thromb. 14:1998;1007-1013.
51. Gilligan D.M., Sack M.N., Guetta V., et al. Effect of antioxidant vitamins on low density lipoprotein oxidation and impaired endothelium-dependent vasodilation in patients with hypercholesterolemia. J Am Coll Cardiol. 24:1994;1611-1617.
52. Ting H.H., Timimi F.K., Haley E.A., et al. Vitamin C improves endothelium-dependent vasodilation in forearm resistance vessels of humans with hypercholesterolemia. Circulation. 95:1997;2617-2622.
53. Wei E.P., Kontos H.A., Christman C.W., DeWitt D.S., Povlishock J.T. Superoxide generation and reversal of acetylcholine-induced cerebral arteriolar dilation after acute hypertension. Circ Res. 57:1985;781-787.
54. Kontos H.A., George E. Brown memorial lecture. Oxygen radicals in cerebral vascular injury. Circ Res. 57:(4):1985;508-516.
55. Rubanyi G.M. Vascular effects of oxygen-derived free radicals. Free Radic Biol Med. 4:(2):1988;107-120.
56. Wilson S.K. Role of oxygen-derived free radicals in acute angiotensin II- induced hypertensive vascular disease in the rat. Circ Res. 66:(3):1990;722-734.
57. Zhang X.M., Ellis E.F. Superoxide dismutase decreases mortality, blood pressure, and cerebral blood flow responses induced by acute hypertension in rats. Stroke. 224:(4):1991;489-494.
58. Nakazono K., Watanabe N., Matsuno K., et al. Does superoxide underlie the pathogenesis of hypertension. Proc Natl Acad Sci USA. 88:1991;10045-10048.
59. Grunfeld S., Hamilton C.A., Mesaros S., et al. Role of superoxide in the depressed nitric oxide production by the endothelium of genetically hypertensive rats. Hypertension. 26:1995;854-857.
60. Laursen J.B., Rajagopalan S., Galis Z., et al. Role of superoxide in angiotensin II-induced but not catecholamine-induced hypertension. Circulation. 95:1997;588-593.
61. Schnackenberg C.G., Welch W.J., Wilcox C.S. Normalization of blood pressure and renal vascular resistance in SHR with a membrane-permeable superoxide dismutase mimetic - Role of nitric oxide. Hypertension. 32:1998;59-64.
62. Sagar S., Kallo I.J., Kaul N., Ganguly N.K., Sharma B.K. Oxygen free radicals in essential hypertension. Mol Cell Biochem. 111:(1-2):1992;103-108.
63. Mehta J.L., Lopez L.M., Chen L., Cox O.E. Alterations in nitric oxide synthase activity, superoxide anion generation, and platelet aggregation in systemic hypertension, and effects of celiprolol. Am J Cardiol. 74:1994;901-905.
64. Panza J.A., Quyyumi A.A., Brush J.E. Jr., Epstein S.E. Abnormal endothelium-dependent vascular relaxation in patients with essential hypertension. N Engl J Med. 323:1990;22-27.
65. Tschudi M.R., Mesaros S., Lüscher T.F., Malinski T. Direct in situ measurement of nitric oxide in mesenteric resistance arteries - Increased decomposition by superoxide in hypertension. Hypertension. 27:1996;32-35.
66. Bauersachs J., Bouloumié A., Mülsch A., et al. Vasodilator dysfunction in aged spontaneously hypertensive rats: changes in NO synthase III and soluble guanylyl cyclase expression, and in superoxide anion production. Cardiovasc Res. 37:(3):1998;772-779.
67. Kojda G., Kottenberg K., Hacker A., Noack E. Alterations of the vascular and the myocardial guanylate cyclase/cGMP-system induced by long-term hypertension in rats. Pharm Acta Helv. 73:1998;27-35.
68. Treasure C.B., Vita J.A., Cox D.A., et al. Endothelium-dependent dilation of the coronary microvasculature is impaired in dilated cardiomyopathy. Circulation. 81:1990;772-779.
69. Ontkean M., Gay R., Greenberg B. Diminished endothelium-derived relaxing factor activity in an experimental model of chronic heart failure. Circ Res. 69:1991;1088-1096.
70. Kubo S.H., Rector T.S., Bank A.J., Williams R.E., Heifetz S.M. Endothelium-dependent vasodilation is attenuated in patients with heart failure. Circulation. 84:1991;1589-1596.
71. Katz S.D., Biasucci L., Sabba C., et al. Impaired endothelium-mediated vasodilation in the peripheral vasculature of patients with congestive heart failure. J Am Coll Cardiol. 19:1992;918-925.
72. Drexler H., Hayoz D., Munzel T., et al. Endothelial function in chronic congestive heart failure. Am J Cardiol. 69:1992;1596-1601.
73. Prasad K., Kalra J. Oxygen free radicals and heart failure. Angiology. 39:1988;417-420.
74. Singal P.K., Kirshenbaum L.A. A relative deficit in antioxidant reserve may contribute in cardiac failure. Can J Cardiol. 6:1990;47-49.
75. McMurray J., Chopra M., Abdullah I., Smith W.E., Dargie H.J. Evidence of oxidative stredd in chronic heart failure in humans. Eur Heart J. 14:1993;1493-1498.
76. Ghatak A., Brar M.J., Agarwal A., et al. Oxy free radical system in heart failure and therapeutic role of oral vitamin E. Int J Cardiol. 57:1996;119-127.
77. Keith M., Geranmayegan A., Sole M.J., et al. Increased oxidative stress in patients with congestive heart failure. J Am Coll Cardiol. 31:1998;1352-1356.
78. Yucel D., Aydogdu S., Cehreli S., et al. Increased oxidative stress in dilated cardiomyopathic heart failure. Clin Chem. 44:1998;148-154.
79. Khaper N., Singal P.K. Effects of afterload-reducing drugs on pathogenesis of antioxidant changes and congestive heart failure in rats. J Am Coll Cardiol. 29:1997;856-861.
80. Miller D.J., MacFarlane N.G. Intracellular effects of free radicals and reactive oxygen species in cardiac muscle. J Hum Hypertens. 9:1995;465-473.
81. Radi R., Rodriguez M., Castro L., Telleri R. Inhibition of mitochondrial electron transport by peroxynitrite. Arch Biochem Biophys. 308:1994;89-95.
82. Castro L., Rodriguez M., Radi R. Aconitase is readily inactivated by peroxynitrite, but not by its precursor, nitric oxide. J Biol Chem. 269:1994;29409-29415.
83. Ishida H., Ichimori K., Hirota Y., Fukahori M., Nakazawa H. Peroxynitrite-induced cardiac myocyte injury. Free Radic Biol Med. 20:1996;343-350.
84. Schulz R., Dodge K.L., Lopaschuk G.D., Clanachan A.S. Peroxynitrite impairs cardiac contractile function by decreasing cardiac efficiency. Am J Physiol. 272:(3 Pt 2):1997;H1212-H1219.
85. Xie Y.W., Kaminski P.M., Wolin M.S. Inhibition of rat cardiac muscle contraction and mitochondrial respiration by endogenous peroxynitrite formation during posthypoxic reoxygenation. Circ Res. 82:1998;891-897.
86. Oyama J., Shimokawa H., Momii H., et al. Role of nitric oxide and peroxynitrite in the cytokine-induced sustained myocardial dysfunction in dogs in vivo. J Clin Invest. 101:1998;2207-2214.
87. Oyama Y., Kawasaki H., Hattori Y., Kanno M. Attenuation of endothelium-dependent relaxation in aorta from diabetic rats. Eur J Pharmacol. 132:1986;75-78.
88. Saenz de Tejada I., Goldstein I., Azadzoi K., Krane R.J., Cohen R.A. Impaired neurogenic and endothelium-mediated relaxation of penile smooth muscle from diabetic men with impotence. N Engl J Med. 320:1989;1025-1030.
89. Pieper G.M. Review of alterations in endothelial nitric oxide production in diabetes - Protective role of arginine on endothelial dysfunction. Hypertension. 31:1998;1047-1060.
90. Tesfamariam B., Cohen R.A. Free radicals mediate endothelial cell dysfunction caused by elevated glucose. Am J Physiol. 263:1992;H321-H326.
91. Langenstroer P., Pieper G.M. Regulation of spontaneous EDRF release in diabetic rat aorta by oxygen free radicals. Am J Physiol. 263:1992;H257-H265.
92. Pieper G.M., Langenstroer P., Siebeneich W. Diabetic-induced endothelial dysfunction in rat aorta: role of hydroxyl radicals. Cardiovasc Res. 34:1997;145-156.
93. Kawamura M., Heinecke J.W., Chait A. Pathophysiological concentrations of glucose promote oxidative modification of low density lipoprotein by a superoxide-dependent pathway. J Clin Invest. 94:1994;771-775.
94. Bucala R., Tracey K.J., Cerami A. Advanced glycosylation products quench nitric oxide and mediate defective endothelium-dependent vasodilatation in experimental diabetes. J Clin Invest. 87:1991;432-438.
95. Morigi M., Angioletti S., Imberti B., et al. Leukocyte-endothelial interaction is augmented by high glucose concentrations and hyperglycemia in a NF-kB-dependent fashion. J Clin Invest. 101:1998;1905-1915.
96. Ellis E.A., Grant M.B., Murray F.T., et al. Increased NADH oxidase activity in the retina of the BBZ/Wor diabetic rat. Free Radic Biol Med. 24:1998;111-120.
97. O'Driscoll G., Green D., Rankin J., Stanton K., Taylor R. Improvement in endothelial function by angiotensin converting enzyme inhibition in insulin-dependent diabetes mellitus. J Clin Invest. 100:1997;678-684.
98. Grankvist K., Marklund S., Taljedal I.B. Superoxide dismutase is a prophylactic against alloxan diabetes. Nature. 294:1981;158-160.
99. Delaney C.A., Tyrberg B., Bouwens L., et al. Sensitivity of human pancreatic islets to peroxynitrite-induced cell dysfunction and death. FEBS Lett. 394:1996;300-306.
100. Suarez-Pinzon W.L., Szabo C., Rabinovitch A. Development of autoimmune diabetes in NOD mice is associated with the formation of peroxynitrite in pancreatic islet beta-cells. Diabetes. 46:1997;907-911.